Construction of predictive model for programmed death-1 inhibitor-related endocrine adverse events by Jiaying SHI, Wei WEI, Ting HAN, Xiao ZHOU, Meng ZHUO, Xiaolin LIN, Tao TAO, Xiuying XIAO

Get full text

Automated interpretation of PD-L1 CPS based on multi-AI models integration strategy in gastric cancer by Ting Han, Meng Zhuo, Ziyu Song, Peilin Chen, Shiting Chen, Wei Zhang, Yuanyuan Zhou, Hong Li, Dadong Zhang, Xiaolin Lin, Zebing Liu, Xiuying Xiao

Get full text

Epithelial NSD2 maintains FMO‐mediated taurine biosynthesis to prevent intestinal barrier disruption by Yue Xu, Xiuying Xiao, Chunxiao Ma, Ziyi Wang, Wenxin Feng, Hanyu Rao, Wei Zhang, Ningyuan Liu, Rebiguli Aji, Xiangjun Meng, Wei‐Qiang Gao, Li Li

Get full text

Optimizing anti-PD-1/PD-L1 therapy efficacy and fecal microbiota transplantation donor selection through gut mycobiome-based enterotype by Muni Hu, Xiaoqiang Zhu, Xiaowen Huang, Li Hua, Xiaolin Lin, Hangyu Zhang, Ye Hu, Tianying Tong, Lingxi Li, Baoqin Xuan, Ying Zhao, Yilu Zhou, Jinmei Ding, Yanru Ma, Yi Jiang, Lijun Ning, Yue Zhang, Zhenyu Wang, Jing-Yuan Fang, Youwei Zhang, Xiuying Xiao, Jie Hong, Huimin Chen, Jiantao Li, Haoyan Chen

Get full text